Blog

WHO Launches Biomanufacturing Training to Boost Global Vaccine Production
🌍 WHO launches Biomanufacturing Workforce Training Initiative to improve bioproduction in LMICs. 🏭💪🔬 Enhancing local vaccine production and building capacity.

Groundbreaking Cancer Drug Shows Remarkable Results
Exciting news! Vidac Pharma reports preclinical success for cancer drug VDA-1275, showing increased efficacy and immune response. 🚀💊🔬

Revolutionary Partnership Creates Gene-Editing Breakthrough
Title: Intellia and ReCode Partner to Develop Gene-Editing Therapies Against CF Excerpt: 🚀 Exciting collaboration between Intellia and ReCode to combat CF using cutting-edge gene-editing technologies! Stay tuned!

FDA Approves Game-Changing Solid Tumor Cell Therapy!
🚀 Iovance receives FDA approval for groundbreaking solid tumor cell therapy! 💪🔬 Stay tuned for more exciting updates! 🌟

Groundbreaking $800m Cancer Partnership Revolutionizes Treatment
🔍 Sorry, the requested page cannot be found. Please go back to the home page. 🏠 AstellasXyphos Kelonia CancerResearch Partnership

Daiichi Sankyo Skyrockets Oncology Power with $1bn Expansion
🔬💰 Daiichi Sankyo expands its oncology portfolio with a $1bn investment, strengthening their position in the industry. 🏥🚀

Say Goodbye to Endotoxins: Proven Strategies Revealed!
📝 Effective Strategies for Endotoxin Removal in Therapeutic Protein Purification explores challenges and solutions to eliminate endotoxins in protein preparations. 🧪

Boost AAV Genome Production with RevIT Enhancer!
🚀 Boost AAV genome production with RevIT™ AAV Enhancer! 🧬💰 Increase titers, streamline workflows, and save costs in gene therapy manufacturing.

Unlocking Flow Cytometry’s Secrets: Consistent Results Made Simple!
🔬⚖️ Consistent quality control & standardization are crucial in flow cytometry for accurate & reliable results. Discover BD FACSLyric™ Flow Cytometer! 👩🔬🔬📊 Note: BD is the sponsor of this article. Register on the website to learn more and download the application note.






